Introduction
fourth, E3-gp19K, has been shown to inhibit target cell The future success of adenovirus vectors for in vivo gene lysis by activated T lymphocytes (CTLs) 15 by binding and therapy depends upon our ability to understand and retaining these molecules in the endoplasmic reticulum, effectively evade the host's immune response towards:
and thus stopping the migration of MHC I alpha chain the virus, cells infected with virus, and the newly molecules to the cell surface. 16, 17 Decreasing cell surface expressed transgene. [1] [2] [3] [4] Some success in 'down-reglevels of MHC I and the expression of proteins which ulating' responses towards the virus and cells infected interfere with TNF are two mechanisms that wild-type with virus have recently been reported. [5] [6] [7] [8] These studies adenovirus utilizes in evading the host immune utilize the administration of systemic immunomodularesponse. 11 tory drugs to achieve prolonged transgene expression by Transgenic mice containing the adenovirus E3 region depleting T cells, interfering with T cell receptor function, with its native promoter have been found not to express or interfering with co-stimulatory signals required for T significant amounts of any E3 proteins in hepatocytes in cell activation.
the absence of E1a protein. 18 Given this information, it The adenovirus E3 region potentially encodes nine proseems unlikely that E3-gp19K is expressed from murine teins, is well conserved between serotypes, and is not hepatocytes following infection with first generation essential for viral replication. [9] [10] [11] Four of these nine proadenovirus vectors, but this remains to be directly teins have been characterized, and appear to function as shown. It has also been demonstrated that constitutive immunoregulatory proteins. 10, 11 Three of these immunoexpression of the adenovirus E3 protein gp19K with ␤-regulatory proteins (14.7k, 14.5k and 10.4k) have been galactosidase in murine hepatocytes 'strongly' decreased the formation of antivector lymphocytes, 19 but it is not clear from this study if this decrease in antivector protein would result in prolonged transgene expression following in vivo transduction of murine hepatocytes, a recombinant adenovirus (Ad.RSV-gp19K) was prepared containing the wild-type (Ad2) E3-gp19K gene 3′ to the Rous sarcoma virus long terminal repeat (RSV-LTR) promoter. This promoter was chosen because we have previously found it to produce high levels of transgene expression in murine hepatocytes following in vivo transduction. 1, 5 This virus and another reporter adenovirus producing human alpha-1-antitrypsin (Ad/RSV-hAAT) were then injected into three congenic strains of mice with class I MHC molecules differing in affinity for gp19K, and the serum level of hAAT protein monitored over time.
Results
Characterization of recombinant adenovirus Ad.RSVgp19K The genomic structure of the recombinant adenovirus, Ad.RSV-gp19K was confirmed by restriction digestion. To ensure that Ad.RSV-gp19K produced a protein of the appropriate size, immunoprecipitation of gp19K protein was performed 48 h after infection of 1 × 10 7 SVB6 murine fibroblasts at an MOI (multiplicity of infection) of 300 with Ad-RSV-gp19K. An MOI of 300 was selected because preliminary experiments with Ad.RSV.␤gal and SVB6 cells demonstrated approximately 80% blue nuclear staining at this MOI (data not shown). The results shown ( Figure 1 , lane C). The migration of the gp19K protein in this size range is predicted from earlier studies and is likely due to abundant glycosylation. immunoprecipitation experiment was performed to estimate the amounts of gp19K protein produced from the heterologous and endogenous promoters in SVB6 cells. To this end, Ad.RSV-gp19K or Ad/RSV-hAAT viruses To demonstrate that Ad.RSV-gp19K produced a functional protein, infected SVB6 fibroblasts were subjected containing the same endogenous E3 region were used to infect SVB6 fibroblasts. Twenty-four hours later, after to staining with antibodies against MHC I proteins and quantified by fluorescence activated cell sorting (FACS) immunoprecipitation, quantification of gp19K protein was performed on a phosphoimager. The results are analysis ( Figure 2) . By 18 h after injection (Figure 2a ), the intensity of MHC I on the fibroblasts was decreased in shown in Table 1 . For two different immunoprecipitations, Ad.RSV-gp19K infected SVB6 fibroblasts produced cells treated with wild-type adenovirus but not in Ad/RSV-hAAT, Ad.RSV-gp19K, or vehicle treated cells. three times more gp19K protein than Ad/RSV-hAAT recombinant vector containing the native E3-gp19K
By 72 h after infection (Figure 2b) , there was an increase in MHC I staining in cells treated with Ad/RSV-hAAT sequences. It is of interest to note that Ad.RSV-gp19K produced about the same amount of gp19K protein as or Ad/RSV-hAAT (E3-) compared with vehicle-treated controls. It is interesting to note that the presence of an that produced following infection with wild-type adenovirus (Ad2) at one-third the MOI.
intact, endogenous E3-gp19K gene in the vector (Ad/RSV-hAAT) did not affect MHC I patterns Balb/k mice were each divided into two groups, and each group was administered two viruses, Ad/RSV-( Figure 2b ). In contrast, the Ad.RSV-gp19K infected fibroblasts showed diminished intensity of MHC I stainhAAT and Ad.RSV-gp19K, or Ad/RSV-hAAT and Ad/RSV-cFIX (as a control). A vector expressing cFIX ing compared with Ad/RSV-hAAT and Ad/RSVhAAT(E3-) infected profiles at 72 h after infection. Fibrowas used as a control because of the concordance of persistence of this protein with hAAT in similar inbred blasts infected with wild-type adenovirus (type 2) showed complete cytopathic effect (CPE) by 72 h and mouse strains. 1, 26 The ratio of the two viruses was 1:3, reporter virus to Ad.RSV-gp19K, and the total number of were not available for analysis. An experiment similar to that shown in Figure 2 using PC3H cells (H-2k adenovirus particles transduced held constant at 8 × 10 9 p.f.u. because this represents at least 20-50 adenovirus haplotype) with surface MHC I molecules with no affinity for gp19K showed no significant decrease in surface genomes per hepatocyte on average, and has been shown not to produce severe liver damage. 2,27,28 To ensure that MHC I abundance following wild-type and recombinant adenovirus infections (data not shown). This allowed us administration of this amount of adenovirus would result in transfected hepatocytes containing multiple copies of to conclude that the decreased abundance of surface MHC I was mediated by expressed gp19K protein and adenovirus genome, the FISH analysis shown in Figure 3 was performed on hepatocyte nuclei isolated 72 h after not the result of a general decrease in transcription following adenovirus infection.
infection with 5 × 10 9 p.f.u. Ad/RSV-hAAT. Hybridization was performed with the 30 kb adenoviral plasmid The immunoprecipitation and FACS analysis taken together demonstrate that the exogenous E3-gp19K propBHG10 as noted in the Materials and methods. The two representative cells shown in Figure 3a demonstrate the tein derived from the transgene in Ad.RSV-gp19K was functional, and in the absence of E1a, some endogenous multiple punctate spots of hybridization, representing 19 and 26 adenovirus genomes within each. This range of E3-gp19K was produced in the transformed cell line SVB6, as previously noted in other cells, 22, 23 but that this hybridization varied between two and 100 punctate spots per nuclei. However, the adenoviral signals seen in the level of gp19K expression did not significantly decrease cell surface MHC class I expression. However, downmajority of nuclei on this slide were similar to that shown in Figure 3 , and there were no signals seen in any of the regulation of surface MHC I levels was more rapidly achieved following wild-type adenovirus infection of nuclei from uninfected animals as demonstrated in Figure 3b . Thus, a 1:3 excess of reporter to Ad.RSV-gp19K SVB6 fibroblasts than compared with surface MHC I levels following infection with Ad.RSV-gp19K.
would assure that relatively few cells would contain only the reporter genome. The serum hAAT levels determined by ELISA are Constitutive expression of gp19K in vivo E3-gp19K gene expression levels from a native versus hetshown in Figure 4 for both groups of Balb/c (a), Balb/k (b), and Balb/b (c) congenic mice. Within each strain of erologous promoter do not necessarily correlate with in vivo patterns of gene expression. However, functional mice, there was no clear difference in the duration of hAAT expression between the mice which did and did studies related to a particular vector can be assessed in tissue culture. E3-gp19K has the highest affinity for MHC not receive Ad.RSV-g19K. However, there is a striking prolongation of serum hAAT levels in the Balb/b mice I molecules of the murine H-2 b haplotype (Balb/b and C57B1/6), an intermediate affinity for the H-2 d haplotype compared with their congenic parental strain Balb/c, regardless of E3-gp19K expression. This duration of (Balb/c), and no affinity for H-2 k (Balb/k). 9, 24, 25 To determine if constitutive expression of gp19K in vivo would hAAT expression is similar to that seen in C57B1/6 mice, 1 which is the H-2 b haplotype donor strain for Balb/b conresult in a prolongation of hAAT reporter gene expression in permissive haplotypes, Balb/c, Balb/b, and genic mice. (Figure 5b , lane 3) suggested that the vast gene expression from the endogenous adenovirus E3 promoter will be weak following in vivo transduction of majority of this gp19K transcript was produced from the E1-inserted transgene and not from the gp19K gene in murine hepatocytes, 18, [21] [22] [23] this had not been previously evaluated using E1-deleted first generation adenovirus the endogenous E3 region. A similar RT-PCR assay with PCR primers specific for hAAT demonstrated the presvectors. The gp19K cDNA used to make Ad.RSV-gp19K encodes the gp19K gene from type 2 adenovirus. While ence of hAAT transcripts in only the mRNA from Ad/RSV-hAAT infected and Ad/RSV-hAAT + Ad.RSVit has high homology at the amino acid level, differences in the nucleotide sequence result in the placement of a gp19K-infected animals (data not shown). unique HindIII site in the middle of the Ad2 gp19K transcript. This sequence difference provides a means of Down-regulation of MHC I following wild-type Ad2 infection but not Ad.RSV-gp19K infection identifying the relative amount of gp19K transcript from the E1 transgene versus the amount of transcript from the Fluorescence activated cell sorting (FACS) was chosen as a means to compare the ability of Ad.RSV-gp19K and native gp19K gene in the E3 region using RT-PCR analysis of mRNA isolated from mouse liver following transwild-type Ad2 to down-regulate MHC I in murine hepatocytes at various times following transduction. C57B1/6 duction with adenovirus ( Figure 5) .
A gp19K-amplified fragment of expected size was mice (H-2 b haplotype) were killed 1, 4 and 14 days after injection of recombinant adenoviruses, and fresh hepatoobtained only from the mRNA of the mouse which cytes prepared, stained and evaluated by FACS. Each of infection (Figure 2b ), was also seen previously in mouse livers in our laboratory 5 and in others 29 and was the panels in Figure 6 show one of two to three representative experiments. Figure 6a shows the profiles obtained mediated at least in part by interferon ␥. By 14 days after infection, MHC I expression levels in for hepatocytes prepared 24 h after infection. The profiles of Ad.RSV-gp19K, Ad/RSV-hAAT and control mice were adenovirus-infected mice returned to baseline (Figure 6c ) and were indistinguishable between groups receiving very similar, while the profile following transduction with wild-type Ad2 showed the largest decrease in MHC adenovirus (recombinant or wild-type) and controls. This normalization of MHC I expression was not related to I abundance of cell surface MHC I by 24 h after transduction.
loss of adenovirus-mediated gene expression, as the level of transgene expression was still robust (not shown), and After 4 days (Figure 6b ), the profiles of hepatocytes from animals infected with recombinant adenoviruses all the exact nature of this normalization remains unknown. It is of interest that the kinetics of MHC regulation with showed a 10-fold increase in surface MHC I compared to hepatocytes from vehicle-treated mice. There was a minithe different adenoviruses were qualitatively similar and consistent between hepatocytes transduced in vivo and mal decrease in surface MHC I expression in mice given Ad.RSV-gp19K compared with the other recombinant cultured fibroblasts. The MHC I studies of transduced hepatocytes from C57B1/6 mice (H-2 b haplotype) demonvectors. Hepatocytes infected with wild-type Ad2 virus also had an increase in surface MHC I expression, but strate that while E3-gp19K can substantially decrease the amount of cell surface MHC I molecules by 24 h after not to the extent seen with the recombinant adenoviruses. This increase in hepatocyte surface MHC I levels, similar infection with wild-type adenovirus (both E1a and E3 present), insufficient E3-gp19K was produced from the to that seen in SVB6 murine fibroblasts following in vitro native E3 promoter (E1a absent) and the RSV-LTR promoter in recombinant adenovirus vectors to significantly alter the cell surface MHC I levels. This, in combination with the general induction of MHC I expression in hepatocytes with wild-type or recombinant adenovirus, makes it unlikely that E3-gp19K alone would be sufficient to regulate cell surface MHC-I levels in vitro, it has no effect on the duration of transgene expression in vivo. It appears that this is because adenovirus induces class I MHC expression on hepatocytes, and that insufficient protein is produced soon enough to produce a detectable decrease in cell surface MHC I levels in vivo. While we have found that the RSV promoter works well in hepatocytes, it typically takes days to obtain robust transgene expression following intravenous infusions. 1, 5 In contrast, previous studies with the native E3 promoter in the presence of E1a have demonstrated maximal gp19K expression only 8 h after infection of cells in vitro. 30 This in vitro data is consistent with our in vivo FACS data, and it will be important to consider in future efforts to constitutively express E3-gp19K, other native E3 proteins, or other viral immunomodulatory proteins such as adenovirus E3-14.7K and E1b 19K proteins. 10, 11 Prolonged survival of pancreatic islet cells isolated from a transgenic mouse expressing the entire E3 region under the control of the insulin II promoter supports the notion that constitutive expression of E3 viral transgenes can have a favorable clinical outcome in tissue transplantation, 31 and serves as a proof-of-principle study for this experimental design. In contrast to our study, these transgenic animals express more than the E3-gp19K protein within numerous tissues, while after adenovirus gene transfer just the transduced cells express only the E3-gp19K protein. Using a murine pneumonia model and a recombinant vaccinia virus constitutively expressing gp19K with a CMV promoter, the presence of gp19K had no effect on virus lethality, nor did it alter the development of a CD8 + infiltrate. 32 These data, showing a similar lack of effect following constitutive expression of gp19K, may also be interpreted as a delay in expression of gp19K by the strong, yet non-native CMV promoter. In another study using various replication-competent adenovirus deletion mutants administered as aerosols to murine airways, these investigators found no difference in CTL generation or in pulmonary infiltrates formed following administration of viruses containing or deleted of gp19K. 33 Even in the absence of IFN-␥, a potent up-regulatory signal for MHC I, the presence or absence of gp19K had no effect on the immune response. 33 It should be noted that while these findings are consistent with the findings of our current study they contradict the previous study of gp19K function in murine liver, 19 which may point of reference for 'maximal' E3-gp19K expression in this murine model system. Thus, the non-gp19K gene prolong transgene expression by down-regulation of products produced from a wild-type virus could in MHC I. theory influence the inflammatory response and indirectly affect MHC I gene expression. One report examining the ability of various adenovirus deletion Discussion mutants to alter cell surface levels of MHC I using FACS analysis has shown that a particular mutant, dl327, which It is the hypothesis of this study that constitutive expression of the native gp19K protein, which has been contains a specific E3 deletion removing the gp19K sequences, demonstrated near wild-type levels of cell shown to down-regulate the development of class I MHC-restricted cytotoxic T lymphocytes directed surface MHC I in the cotton rat model system. 34 This strongly suggests that class I down-regulation seen with towards adenovirus-infected hepatocytes, 19 would result in prolonged transgene expression. Our current data sugwild-type adenovirus was the result of gp19k expression. Additionally, recent studies have shown that CTL gest that while Ad.RSV-gp19K can modestly down-358 recognition of CMV infected cells occurs before endogenRecombinant adenoviruses Construction of the recombinant E1-deficient Ad5 vectors ous gene (and thus transgene) expression. 35 If this were the case for recombinant adenoviruses, the ability to alter Ad/RSV-hAAT (endogenous gp19K '+'), 38 Ad/RSV-cFIX (endogenous gp19K '+'), 26 and Ad.RSV-␤gal (produces ␤-the CTL response by constitutive expression of proteins that must be synthesized de novo may be limited, and galactosidase and is endogenous gp19K '−') 39 have been previously described. Wild-type adenovirus serotype 2 require the administration of immunomodulatory agents such as CTLA4Ig prior to recombinant adenovirus transwas obtained from ATCC (Rockville, MD, USA). The E3-gp19K cDNA clone from Ad2 was graciously provided duction. 5 Unfortunately, whether or not MHC I presentation on by Dr W Wold from Washington University in St Louis, MO, USA. The recombinant adenovirus constitutively hepatocytes, liver non-parenchymal cells, and/or nonliver cells are responsible for initiation of class I-mediated expressing E3-gp19K (Ad.RSV-gp19K) was prepared by cloning gp19K as an EcoRI fragment into the left-end immune events is not known. A better understanding of both the induction and effector phase of the immune adenoviral vector pXCJL directly downstream of the Rous sarcoma virus LTR promoter and directly upstream response may assist in designing more rational strategies for immune evasion by interference with class I presenof the bovine growth hormone polyadenylation signal.
38
The appropriate orientation was ascertained by restrictation. One possibility would be to engineer vectors that express the herpes ICP47 protein which by interfering tion digestion. Recombinant adenovirus was rescued following co-transfection of this construct with PJM17 40 in with peptide transporters (TAP), inhibits the transport of MHC I molecules to the cell surface. 36, 37 Because E3-293 cells. 40, 41 Recovered plaques were expanded and characterized by restriction digestion. 41 Desired recombigp19K functions distal to ICP47 perhaps coexpression of both proteins would be optimal for down-regulating nants were grown in large scale and then purified and concentrated on two cesium chloride gradients. 41 Each class I expression.
An unexpected finding was the discordance of transvirus preparation was assayed for wild-type contamination, 1 and quantified both spectrophotometrically gene expression between the three congenic strains used in the study. The alteration in duration of transgene (optical density 260 nm) and by plaque assay. 41 The recombinant adenovirus expressing human ␣-1-antitrypexpression between the three congenic Balb/c, Balb/k, and Balb/b mice strongly suggests that the H-2 locus is sin (hAAT) without an endogenous E3-gp19K gene Ad/RSV-hAAT(E3-) was prepared by cotransfecting the responsible for the prolonged transgene expression particularly in the Balb/b background. Our previous study 1 previously described left-end vector containing hAAT downstream from the Rous sarcoma virus promoter and demonstrated that the duration of expression did not correlate with the H-2 locus for several major determinants upstream from the bovine growth hormone polyadenylation signal 38 with pBHG10. 42 Recombinant plaques were (D, L and K), but also suggested that other genetic loci derived from a paternal founder strain may be the detercharacterized and expanded as described above. minant for this strain variation. With this additional finding, the possibility arises that multiple loci are Immunoprecipitation analysis of E3 gp19K protein SVB6 and PC3H murine fibroblasts expressing H-2 b and responsible for the murine strain variation in transgene H-2 k MHC I molecules respectively were graciously proexpression. Additional studies are currently in progress vided by Dr Linda Gooding of Emory University. Cells to investigate the biological basis for this strain variawere metabolically labelled 4 h before harvesting in bility.
150 Ci of ICN 35 S translabel as previously described. 20 The labeled cells were mechanically removed from the 10-cm tissue culture dishes, washed in PBS, and lysed for
Materials and methods
30 min on ice in TEN (20 mm Tris, 1 mm EDTA, and 0.5% NP40 pH 7.5) buffer containing a 1:100 volume of ×100 freshly prepared protease inhibitor mixture (77 g/ml Animal studies aprotinin (Sigma, St Louis, MO, USA), 0.1 mm leupeptin Animal studies were performed in accordance with the (Sigma), 1.5 m pepstatin (Sigma), and 0.5 mm phenylmeinstitutional guidelines set out by the University of thylsulfonyl fluoride (Calbiochem)). Following a 15 min Washington. Female C57B1/6, C3H, Balb/b, Balb/k and centrifugation at maximum speed in an Eppendorf Balb/c mice were all obtained from Jackson Laboratories microcentrifuge, the supernatant was removed, and two (Bar Harbor, ME, USA) at 5-6 weeks of age and housed 2 l aliquots counted on a Beckman scintillation counter in SPF facilities. Mice were injected with recombinant (Beckman, Palo Alto, CA, USA). The gp19K protein was adenovirus diluted to 150 l in DME medium (Gibco immunoprecipitated from 10 7 c.p.m. of cytosol with Ad2 BRL, Gaithersburg, MD, USA) by tail vein injection, or gp19K terminal peptide antibody provided by Dr WSM by infusion through a portal vein catheter as previously Wold 30 preloaded on to protein A-sepharose resin at 4°C described. 28 Previous studies have shown that infusion of with rocking for 6-8 h. Following immunoprecipitation, 8 × 10 9 recombinant adenovirus particles results in each the resin was washed three times in high salt buffer (TEN hepatocyte on average being transduced with 20 to 50 plus 400 mm NaCl), and then twice in 50 mm Tris pH 6.8. adenovirus genomes.
2,28 Blood samples for serum protein The washed resin pellet was then extracted into 20 l of analysis were obtained by the retro-orbital technique.
2 × SDS-PAGE sample buffer (0.5 m Tris, 4% SDS (w/v), Mice found to have serum hAAT levels less than 0.1% bromophenol blue, 40% glycerol (v/v), and 10% 500 ng/ml on serum samples taken on days 3-7, and mercaptoethanol (v/v), pH 6.8), and diluted with 1× samthought to have received poor injections, were removed ple buffer to a final volume of 60 l. The samples were from the study. The animals were killed by cervical dislodenatured by boiling for 5 min after adding 5% BME, and then analyzed by SDS-PAGE with a 15% separating gel cation.
as previously described. 20 Following electrophoresis, the gated goat anti-murine H-2D b MHC I (Pharmingen, San Diego, CA, USA), and the other with a PE-conjugated gel was vacuum-dried, and visualized by autoradiography or phosphoimager analysis (Molecular Dynamics, goat isotype control antibody (Pharmingen). Following the incubation, the cells were washed three times with Sunnyvale, CA, USA). 'Relative amount' of gp19K was determined by subtracting the background from the pho-400 l of PBS/FCS, and the final pellet fixed in 60 l of 2% paraformaldehyde. FACS analysis was typically sphoimager raw data count for similar areas around the gp19K protein band, and then normalizing that number performed within 24 h of staining. FACS analysis of SVB6 murine fibroblasts was perforto the amount of a 46 kb nonspecific binding band. med essentially as described for hepatocytes except that the staining involved two sequential steps. First, the cells Analysis of murine serum Serum human alpha-1-antitrypsin (hAAT) levels were were incubated with either biotinylated rabbit antimurine H-2D b or H-2K k MHC I primary antibody determined by ELISA 5 on duplicate samples using multiple dilutions to assure that readings were made on the (Pharmingen) and then, after three washes with PBS/FCS, incubated with PE conjugated to streptavidin linear portion of the standard curve. Serum neutralizing antibody analysis was performed as previously (Pharmingen). The fluorescein profiles shown for both SVB6 fibrodescribed. 2, 5 blasts and the murine hepatocytes were determined by analyzing 20 000 cells on a Becton Dickinson FACScan RT-PCR analysis of transduced murine hepatocytes Messenger RNA from snap-frozen C3H murine liver flow cytometer (Becton Dickinson, San Jose, CA, USA), and were overlayed with Repoman II software (Truefacts samples transduced with various recombinant adenovirus constructs 1 week before liver harvesting was preSoftware, Seattle, WA, USA) using normalization and five-point curve smoothing function. pared using the Invitrogen mRNA isolation kit (Invitrogen, Carlsbad, CA, USA). Serum hAAT levels of Fluorescein in situ hybridization (FISH) of murine blood samples taken before death were used to verify hepatocyte nuclei that the animal had been successfully transduced. RTHepatocytes were prepared for FISH analysis as outlined PCR was performed on 1 g of mRNA, using the PCR above for FACS analysis. 43 FISH analysis was performed buffer provided in the kit and an Ericomp thermocycler as previously described 44 with the following modififor 30 cycles of 94°C (1 min), 55°C (2 min) and 72°C
cations. After quantification of the hepatocytes, they were (3 min) with the following gp19K specific primers: (5′-placed in 10 volumes of hypotonic saline (75 mm KCl) for 3′)CTGCGTCTGCTTTTGTATT and TCAGCTTTTTAAA 15 min, and then fixed twice in a freshly prepared sol-CGCTGG.
ution of methanol and acetic acid (3:1 respectively). Cells were then either stored at −20°C or dropped on to micro-FACS analysis of murine hepatocytes and cultured scope slides. The plasmid pBHG10, 42 was labeled using fibroblasts the DIG-Nick translation mix from Boehringer Hepatocytes were prepared for FACS analysis as preMannheim (Indianapolis, IN, USA). Fixed slides were viously described. 43 Following the last centrifugation hybridized for 12 to 18 h at 37°C in standard hybridizstep, the cells were counted and viability was assessed ation solution containing 10 g Sigma Cot1 DNA and with trypan blye staining. Routinely, 1 × 10 7 hepatocytes then blocked and washed as described. The immunocytowere obtained with 70 to 80% viability.
chemical detection was performed in 4× SSC containing SVB6 and PC3H fibroblasts were grown in DMEM con-1% BSA in three rounds with murine anti-digoxin, FITC taining 10% fetal calf serum (Gibco). Fiboblasts were harrabbit anti-mouse, and FITC goat anti-rabbit antibodies vested by washing twice in PBS followed by a 5-min respectively all from Sigma at 1:1000 dilutions separated incubation in PBS containing 0.1% EDTA. Staining for by three, 3-min washes. After the final wash, the nuclei flow cytometry was performed immediately following were place in antifade and 2 m DAPI (4′,6′-diamidinofibroblast isolation.
2-phenylindole), and stored at 4°C until viewing. Fluorescence activated cell sorting (FACS) analysis was determined essentially as previously described for cultured fibroblasts. 20 Hepatocytes were prepared on days Acknowledgements 1, 4 and 14 following tail vein injection of recombinant We thank Drs WSM Wold and T Hemersten for graadenovirus (days 4 and 14) or infusion via a portal vein ciously providing the Ad2 gp19K cDNA along with Ccatheter (day 1). Ad.RSV-␤gal was used where indicated terminal peptide antibody, and Leonard Meuse, Brian as a control in some experiments since it does not contain Winther, Dr MJ Vrancken-Peeters and Dr Gijsbert Patijn the native gp19K gene in the E3 region. The wild-type for their technical assistance. This work was supported adenovirus was mixed with the control adenovirus by NIH grant DK49022. DBS was the recipient of the Ad.RSV-␤gal so that similar amounts of adenovirus NHF Judith Graham Pool Fellowship. would be transduced, and because severe immediate toxicity is seen in animals following large injections of wildtype virus. On day 3 serum samples were obtained from was incubated 30 min on ice in the dark with PE-conju-
